Skip to main content
Log in

Spica Prunella extract inhibits phosphorylation of JNK, ERK and IκBα signals during osteoclastogenesis

  • Research Article
  • Published:
Food Science and Biotechnology Aims and scope Submit manuscript

Abstract

Since the 17th century Spica Prunella has been used as a medicinal herb. Dried and pulverized Spica Prunella samples were extracted and used in these experiments. In this study, the effects of Spica Prunella extract (SPE) on RANKL (receptor activator of nuclear factor κB ligand)-induced osteoclastogenesis were examined. Actin ring formation, a typical marker of osteoclastogenesis, was inhibited by SPE without any toxicity. There was also a marked inhibition in the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells in bone marrow-derived monocytes (BMMs). SPE also suppressed phosphorylation of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinases (ERK) both of which are signals of the mitogen-activated protein kinases (MAPKs) signaling pathway. Additionally, SPE inhibited IκBα (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha) signaling pathway, which is an important factor in osteoclastogenesis. These results indicate that SPE might suppress osteoclast differentiation by inhibiting the phosphorylation of JNK and ERK in MAPK and NF-κB signaling pathways which act as messengers in the RANKL-induced osteoclast differentiation pathway. This means that SPE could potentially have great therapeutic usage in treating bone erosive diseases such as rheumatoid arthritis or in preventing metastasis associated with bone loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stains JP, Civitelli R. Cell-to-cell interactions in bone. Biochem. Bioph. Res. Co. 18: 721–727 (2005)

    Article  Google Scholar 

  2. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 15: 337–342 (2003)

    Article  Google Scholar 

  3. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4: 638–649 (2003)

    Article  CAS  Google Scholar 

  4. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 17: 165–176 (1998)

    Article  Google Scholar 

  5. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345–357 (1999)

    Article  CAS  Google Scholar 

  6. Karlström E, Ek-Rylander B, Wendel M, Andersson G. RANKL induces components of the extrinsic coagulation pathway in osteoclasts. Biochem. Bioph. Res. Co. 394: 593–599 (2010)

    Article  Google Scholar 

  7. Teitelbaum SL. Bone resorption by osteoclasts. Science 289: 1504–1508 (2000)

    Article  CAS  Google Scholar 

  8. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T. Nishihara T, Koga T, Martin TJ, Suda T. Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. P. Natl. Acad. Sci. USA 87: 7260–7264 (1990)

    Article  CAS  Google Scholar 

  9. Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K. RANKLstimulated TNF alpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways. Biochem. Bioph. Res. Co. 357: 945–950 (2007)

    Article  CAS  Google Scholar 

  10. Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, Kim HH. Tumor necrosis factoralpha supports the survival of osteoclasts through the activation of Akt and ERK. J. Biol. Chem. 276: 49343–49349 (2001)

    Article  CAS  Google Scholar 

  11. Lee ZH, Kim HH. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Bioph. Res. Co. 305: 211–214 (2003)

    Article  CAS  Google Scholar 

  12. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889–901 (2002)

    Article  CAS  Google Scholar 

  13. Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D, Dougall WC. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J. Biol. Chem. 277: 44347–44356 (2002)

    Article  CAS  Google Scholar 

  14. Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem. Bioph. Res. Co. 359: 1044–1049 (2007)

    Article  CAS  Google Scholar 

  15. Psotova J, Kolar M, Sousek J, Svagera Z, Vicar J, Ulrichova J. Biological activities of Prunella vulgaris extract. Phytother. Res. 17: 1082–1087 (2003)

    Article  Google Scholar 

  16. Han EH, Choi JH, Hwang YP, Park HJ, Choi CY, Chung YC, Seo JK, Jeong HG. Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food. Chem. Toxicol. 47: 62–69 (2009)

    Article  CAS  Google Scholar 

  17. Kim SY, Kim SH, Shin HY, Lim JP, Chae BS, Park JS, Hong SG, Kim MS, Jo DG, Park WH, Shin TY. Effects of Prunella vulgaris on mast cell-mediated allergic reaction and inflammatory cytokine production. Exp. Biol. Med. 232: 921–926 (2007)

    CAS  Google Scholar 

  18. Collins NH, Lessey EC, DuSell CD, McDonnell DP, Fowler L, Palomino WA, Illera MJ, Yu X, Mo B, Houwing AM, Lessey BA. Characterization of antiestrogenic activity of the Chinese herb, prunella vulgaris, using in vitro and in vivo (Mouse Xenograft) models. Biol. Reprod. 80: 375–383 (2009)

    Article  CAS  Google Scholar 

  19. Park SJ, Kim DH, Lee IK, Jung WY, Park DH, Kim JM, Lee KR, Lee KT, Shin CY, Cheong JH, Ko KH, Ryu JH. The ameliorating effect of the extract of the flower of Prunella vulgaris var. lilacina on drug-induced memory impairments in mice. Food Chem. Toxicol. 48: 1671–1676 (2010)

    Article  CAS  Google Scholar 

  20. Choi JH, Han EH, Hwang YP, Choi JM, Choi CY, Chung YC, Seo JK, Jeong HG. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-κB-dependent MMP-9 expression. Food. Chem. Toxicol. 48: 564–571 (2010)

    Article  CAS  Google Scholar 

  21. Kim SW, Lee CH, Jung HK, Jo SS, Lee HK, Park YS. Effects of oleanolic acid and its derivatives on the differentiation of MC3T3-E1 osteoblastic cell. Korean J. Medicinal Crop. Sci. 19: 491–500 (2011)

    Article  Google Scholar 

  22. Xu HX, Lee SH, Lee SF, White RL, Blay J. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res. 44: 43–54 (1999)

    Article  CAS  Google Scholar 

  23. Ryu SY, Oak MH, Yoon SK, Cho DI, Yoo GS, Kim TS, Kim KM. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med. 66: 358–360 (2000)

    Article  CAS  Google Scholar 

  24. Lamaison JL, Petitjean-Freytet C, Carnat A. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharm. Acta Helv. 66: 185–188 (1991)

    CAS  Google Scholar 

  25. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. The phosphatidylinositol 3-kinase, p38, and extracellular signalregulated kinase pathways are involved in osteoclast differentiation. Bone 30: 71–77 (2002)

    Article  CAS  Google Scholar 

  26. Kim K, Kim JH, Lee J, Jin HM, Lee SH, Fisher DE, Kook H, Kim KK, Choi Y, Kim N. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 280: 35209–35216 (2005)

    Article  CAS  Google Scholar 

  27. Ha H, Ho J, Shin S, Kim H, Koo S, Kim IH, Kim C. Effects of Eucommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch. Pharm. Res. 391: 789–794 (2010)

    Google Scholar 

  28. Masuda K, Ikeuchi M, Koyama T, Yamaguchi K, Woo JT, Nishimura T, Yazawa K. Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo. J. Bone Miner. Metab. 26: 123–129 (2008)

    Article  Google Scholar 

  29. Kim TH, Kim HJ, Lee SH, Kim SY. Potent inhibitory effect of Foeniculum vulgare Miller extract on osteoclast differentiation and ovariectomy-induced bone loss. Int. J. Mol. Med. 29: 1053–1059 (2012)

    Google Scholar 

  30. Nakashima T, Takayanagi H. New regulation mechanisms of osteoclast differentiation. Ann. NY. Acad. Sci. 1240: E13–E18 (2012)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Il Keun Kwon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ko, WK., Cho, JY., Moon, HJ. et al. Spica Prunella extract inhibits phosphorylation of JNK, ERK and IκBα signals during osteoclastogenesis. Food Sci Biotechnol 22, 1691–1698 (2013). https://doi.org/10.1007/s10068-013-0268-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10068-013-0268-5

Keywords

Navigation